ArticlesBioPharmaDownstreamRegulatoryUpstream November 3, 2023 Digitalization: The Route to Biopharma 4.0 Industry 4.0, also known as the Fourth Industrial Revolution (4IR), will result in the digital... admin-element
ArticlesBioPharmaDownstream October 6, 2023 How can you harness the potential of nucleic acid therapeutics? At Cytiva, the new team is here to support you. We can help you throughout… admin-element
ArticlesBioPharma July 28, 2023 Weighing the Benefits of Single-Use Consumables While the debate between stainless steel and single-use systems (SUS) will continue to rage for... admin-element
ArticlesBioPharma July 13, 2023 Pulling Out All the Stops in mAb Manufacturing While the biopharma industry is pushing the barriers with antibody development, it must also contend… admin-element
ArticlesBioPharma July 13, 2023 Get a strong start in oligonucleotide manufacturing Oligonucleotide therapeutics hold incredible promise. How can you harness their full potential? admin-element
ArticlesBioPharmaUpstream June 29, 2023 Future-proof your AAV process with a complete producer cell line – just induce and grow Stable producer cell lines helped to make mAb therapies the powerhouses they are today. admin-element
ArticlesBioPharma June 13, 2023 BetaLife Wins Cytiva’s First BioChallenge Competition in Southeast Asia Southeast Asia BioChallenge received applications from companies with interests in four different therapeutic areas. admin-element
ArticlesBioPharmaUpstream June 13, 2023 Pushing the Barriers in Next-Gen Antibody Development Continued development of new and next-generation antibodies is spurred by the increasing demand for more… admin-element
ArticlesBioPharma June 13, 2023 Get to know: oligonucleotide synthesis workflow This free interactive course introduces you to synthetic oligonucleotides, applications they’re used in, and how… admin-element
ArticlesBioPharma June 13, 2023 Simulation gets therapies to patients faster and smarter Digital solutions are helping to decrease therapeutic time to market but remain challenging – learn… admin-element